Tea polyphenols

About us
Green tea extract
civilization of tea
Herb extract
Biochemistry products
Chinese herb
Material base
Equipment
E-shopping
corona-fz@263.net
Chinese
BIG5

 

DOSAGE OF ANTICANCER HERBAL

PART A PART B PART C
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pingying: Moyu
English: Rivier Giantarum, Devil's-tongue
Latin: Amorphallus riuieri Durieu

Sources:The tuber of Amorphallus riuieri Durieu Family Araceae.

Constituents:Containing glucomannan and konjacmannan, etc.

Actinos: Konjacmannan interfered metabolism of cancer cells. Hot water extract of the herb has 49.8% of inhibiting tumor growth rate against S180. Refined powder of the herb has inbihitory action against S180, ESC, HepS murine tumors. With a dose of 25,50 and 110mg/kg daily ip for 8 days, inhi- bit ory rates for S180 were 65.375, 58.755 and 57.20% and for ESC ig, the inhibitory rates were 50%, 54.025 and 42.86%. With a dose of 50 and 100mg/kg ig daily for 8 days, the inhibitory rates were 36.62% and 34.075 against HepS.It has remarkable diference compared with contrast (P<0.01 ). Glucomannan has inhibitory action against spontaneous liver tumors on mice and dimethyl hydrazine induced carcinoma on rats. The refined powd- er has remarkable inhibitory action against N-methyl-N-nitrosoguanidine induced lung cancer.

Indications:

(1) Put 60g of the herb into 20 cm inestinal canal of animal and tied up both ends of the canal. The canal was boiled in water for 4 hours and then was taken to treat colonic carcinoma.

(2) Experimental formula for carcinoma of parotid, breast cancer, lymphoma and intracranial tumor:
Tuber Amorphophalli 30g
Radix Isatidis 30g
Flos Lonicerae 15g
Radix Sophorae Tonkinensis 15g

(3) Experimental formula for esophageal cancer:
Rhizoma Pinelliae 30g
Rhizoma Arisaematis 90g
Tuber Amorphophalli 90g
Radix Actinidiae Chinensis 90g
Radix Aconiti Kusnezoffii 15g
Zheng Ling Dan 15g

The herbs were decocted for more than 2 hours and the decoction was taken daily. Shanghai Tianping hospital used the formula and combined with low dose chemotherapy by point-injection to treat 56 cases of esopha- geal cancer. The clinical result showed that effectiveness was in 36 cases, inefficacy was in 20 cases and the total effective rate was 64%.

  
 

All Copy: FuZhou Corona Science & Technology Development Co.,Ltd.
Head Office Tel:  86-591-8376-9772 ;  8376-9751    Fax:  86-591-8376-9723
Copyright© 2001-2008 All right reserved